Search Results (284)
Documents on Products Liability, Pharmaceuticals, Internet & E-Commerce
Show: results per page
|FDA Publishes Revised Guidance on Product Tracing Requirements for Dispensers|
Carolyn A. Alenci, Rachael G. Pontikes; Duane Morris LLP;
November 30, 2015, previously published on November 4, 2015On November 27, 2013, the Drug Supply Chain Security Act (DSCSA) was enacted “to build an electronic, interoperable system by November 27, 2023, which will identify and trace certain prescription drugs as they are distributed in the United States.” This year, trading partners were...
|$8.2M Verdict In Texas Benzene Trial Against DuPont|
Waters Kraus LLP;
October 26, 2015, previously published on October 22, 2015A Dallas, Texas jury has awarded $8.2 million to a 60-year-old Texas man battling MDS/AML, a form of leukemia caused by his exposure to benzene contained in paint and thinners manufactured by E.I. Du Pont De Nemours (DuPont). Virgil Hood handled DuPont’s toxic products on the job daily in...
|Public Statements Made by Pharmaceutical and Biotech Company Executives May Raise FDA's Hackles if They Do Not Meet Basic Requirements for Promotional Communications|
Joanne S. Hawana; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.;
June 26, 2015, previously published on June 23, 2015For players in the highly regulated pharmaceutical and health care industries, it is common knowledge that manufacturers and distributors of FDA-regulated products are required to promote their products in compliance with the Federal Food, Drug, and Cosmetic Act (the Act) and FDA’s...
|Federal Judge Makes Important Ruling in Xarelto Lawsuits|
Waters Kraus LLP;
June 17, 2015, previously published on June 1, 2015As the number of Xarelto lawsuits rises due to the drug’s link to uncontrollable bleeding in patients, cases filed in federal court have been assigned to a single judge in the Eastern District of Louisiana — Judge Eldon Fallon. In May 2015, Judge Fallon ordered lawyers in the Xarelto...
|What’s Really in Your Supplements?|
Selina A. Billington; Wilson Elser Moskowitz Edelman & Dicker LLP;
April 15, 2015, previously published on March 16, 2015New York State Attorney General’s Investigation Has Sparked a Coalition of State Attorneys General Against Herbal Supplement Manufacturers: What does this mean for the industry as a whole in terms of product liability exposure?
|J&J and Bayer Launch New Xarelto Study|
Waters Kraus LLP;
April 7, 2015, previously published on March 20, 2015Johnson & Johnson and Bayer are reportedly seeking additional Food and Drug Administration (FDA) approval for Xarelto, the companies’ lucrative blood thinner that many lawsuits claim can cause injuries and death from uncontrollable bleeding.
|States with Medical Marijuana See Falling Opioid Death Rate|
Stephen J. Burg; Burg Simpson Eldredge Hersh & Jardine, P.C.;
March 25, 2015, previously published on January 23, 2015Researchers from the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center discovered the number of opioid overdoses decreased overtime in states with legalized marijuana.
|FDA Establishes the Office of Pharmaceutical Quality|
Duane Morris LLP;
March 3, 2015, previously published on February 23, 2015In a press conference earlier this year, Dr. Janet Woodcock, head of the U.S. Food and Drug Administration's (FDA) pharmaceutical division, stated that the FDA has been working on "establish[ing] consistent quality standards for all drugs, whether brand name or generic" over the past 10...
|FDA Publishes Second Draft Guidance for Further Clarification of Drug Supply Chain Security Act|
Carolyn A. Alenci, Frederick R. Ball; Duane Morris LLP;
December 10, 2014, previously published on November 17, 2014Earlier this year, the U.S. Food and Drug Administration (FDA) requested information and commentary for the implementation of the Drug Supply Chain Security Act (DSCSA) that in part "establishes a Federal system for tracing prescription drug products through the pharmaceutical distribution...
|Failure-to-Update Claims Against Generic Manufacturers Remain Viable|
Laura J. Gust; Baker Sterchi Cowden & Rice, L.L.C.;
November 12, 2014, previously published on October 16, 2014In Franzman v. Wyeth, Inc., et al., case number ED100312, the Missouri Court of Appeals for the Eastern District recently reversed the trial court’s judgment in favor of the manufacturers of the generic form of Reglan (the “Generic Defendants”) on the portion of Franzman’s...